Bid | Ask | |
Price | n.a. | n.a. |
Volume | n.a. | n.a. |
Change compared with previous day | n.a. | n.a. |
Time | n.a. | n.a. |
Date | n.a. | n.a. |
Currency | USD | |
Nominal amount | 1'000.00 | |
Exchange | ZKB | |
Life cycle | in subscription, indicative |
Daily high/low | n.a. / n.a. |
All-time high/low | n.a. / n.a. |
Performance of structured product since issue | n.a. |
Performance of underlying since issue | n.a. |
Risk | |
SSPA VaR | n.a. |
SSPA risk rating | n.a. |
Volatility | |
30-day volatility | |
100-day volatility |
Capital protection on expiry | 100.00% |
Strike | 6'299.19 (100.00%) |
Participation | 50.00% |
Cap | n.a. |
Distance to cap in% | n.a. |
Minimum repayment | 1'000.00 |
Maximum repayment | n.a. |
Maximum return | n.a. |
TER p.a. | n.a. |
ZKB Barrier Reverse Convertible on worst of Eli Lilly & Co/Novo Nordisk A/S/Unitedhealth Group I... 144651439 / CH1446514395 |
ZKB Barrier Reverse Convertible auf Novo Nordisk A/S 144652645 / CH1446526456 |
0.63% (0.50% p.a.) ZKB Barrier Reverse Convertible Last Look on worst of mit Partizipation Straumann... 142530900 / CH1425309007 |
0.63% (0.50% p.a.) ZKB Barrier Reverse Convertible Last Look on worst of mit Partizipation Straumann... 142530894 / CH1425308942 |
ZKB Reverse Convertible auf Novo Nordisk A/S 140250655 / CH1402506559 |